Hanne Verschuere

Development and validation of a high-throughput screening pipeline of compound libraries to target EMT

Sven Jonckheere, Joachim Taminau (UGent) , Jamie Adams, Jef Haerinck (UGent) , Jordy De Coninck (UGent) , Jeroen Verstappe (UGent) , Kato De Clercq (UGent) , Evelien Peeters (UGent) , Alexander Gheldof (UGent) , Eva De Smedt (UGent) , et al.

(2025) CELL DEATH AND DIFFERENTIATION.

Add to list

Journal Article
A1
open access

Enhancing anti-tumor immunity through intratumoral combination therapy with amphiphilic conjugates of oxaliplatin and imidazoquinoline TLR7/8 agonist

Hanne Verschuere (UGent) , Sabah Kasmi (UGent) , Lutz Nuhn (UGent) , Sènan Mickaël D'Almeida, Qiwen Zhu, Zifu Zhong (UGent) , Sandy Adjemian Catani (UGent) , Benoit Louage (UGent) , Jana De Vrieze, Haijun Yu, et al.

(2025) RSC ADVANCES. 15(15). p.11662-11674

Add to list

PhD Thesis

Impact of EMT on regulated cell death and immune activation in colorectal cancer

Hanne Verschuere

(2023)

Add to list

Journal Article
A1
open access

Exploring the therapeutic potential of ectoine in Duchenne Muscular Dystrophy : comparison with taurine, a supplement with known beneficial effects in the mdx mouse

Caroline Merckx, Jana Zschüntzsch, Stefanie Meyer, Robrecht Raedt (UGent) , Hanne Verschuere, Jens Schmidt, Boel De Paepe (UGent) and Jan De Bleecker (UGent)

(2022) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 23(17).

Add to list

Journal Article
A1
open access

MLKL deficiency in BrafV600EPten-/- melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice

Sofie Martens, Nozomi Takahashi (UGent) , Gillian Blancke (UGent) , Niels Vandamme (UGent) , Hanne Verschuere (UGent) , Tatyana Divert (UGent) , Marnik Vuylsteke, Geert Berx (UGent) and Peter Vandenabeele (UGent)

(2022) CELL DEATH & DISEASE. 13(4).

Add to list

Immunodominant AH1 antigen-deficient necroptotic, but not apoptotic, murine cancer cells induce antitumor protection

Tania Love Aaes (UGent) , Hanne Verschuere, Agnieszka Kaczmarek (UGent) , Liesbeth Heyndrickx (UGent) , Bartosz Wiernicki, Iris Delrue (UGent) , Bram De Craene (UGent) , Joachim Taminau (UGent) , Tinneke Delvaeye (UGent) , Mathieu Bertrand (UGent) , et al.

(2020) JOURNAL OF IMMUNOLOGY. 204(4). p.775-787

Academic Bibliography

Hanne Verschuere

Development and validation of a high-throughput screening pipeline of compound libraries to target EMT

Enhancing anti-tumor immunity through intratumoral combination therapy with amphiphilic conjugates of oxaliplatin and imidazoquinoline TLR7/8 agonist

Impact of EMT on regulated cell death and immune activation in colorectal cancer

Exploring the therapeutic potential of ectoine in Duchenne Muscular Dystrophy : comparison with taurine, a supplement with known beneficial effects in the mdx mouse

MLKL deficiency in BrafV600EPten-/- melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice

Immunodominant AH1 antigen-deficient necroptotic, but not apoptotic, murine cancer cells induce antitumor protection

Contents

Support

Contact